Taro Pharmaceutical Industries Ltd

TARO64

$42.970.00%$0.00

TARO64

$42.97

0.00%$0.00

Performance History

Key Stats
Open	$42.97
Prev. Close	$42.97
EPS	1.43
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

	LOW	HIGH
Day Range	42.89	42.98
52 Week Range	32.67	45.76

Ratios







EPS	1.43

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Taro Pharmaceutical Industries Ltd (TARO)

Taro Pharmaceutical Industries Ltd (TARO) is a renowned pharmaceutical company with a rich history and successful track record. The company, headquartered in Israel, is known for its focus on developing and manufacturing high-quality medications to meet the needs of patients worldwide. TARO has a strong emphasis on research and development, ensuring that they stay at the forefront of medical innovation.

As of the latest data, TARO's stock price has shown steady growth over the years. Investors have benefited from the consistent performance of TARO, with the stock price reaching new highs. This positive trend is indicative of the company's robust financials and promising future prospects. TARO's stock is traded on various exchanges, attracting both institutional and retail investors alike.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Uday V. Baldota
Headquarters: Haifa
Employees: 1554
Exchange: NYSE

add Taro Pharmaceutical Industries Ltd to watchlist

Keep an eye on Taro Pharmaceutical Industries Ltd

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Taro Pharmaceutical Industries Ltd's (TARO) price per share?

The current price per share for Taro Pharmaceutical Industries Ltd (TARO) is $42.97. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Taro Pharmaceutical Industries Ltd (TARO)?

For Taro Pharmaceutical Industries Ltd (TARO), the 52-week high is $45.76, which is 6.49% from the current price. The 52-week low is $32.67, the current price is 31.53% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Taro Pharmaceutical Industries Ltd (TARO) a growth stock?

Taro Pharmaceutical Industries Ltd (TARO) has shown an average price growth of -3.55% over the past three years. It has received a score of 45 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Taro Pharmaceutical Industries Ltd as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Taro Pharmaceutical Industries Ltd (TARO) stock price performance year to date (YTD)?

As of the latest data, Taro Pharmaceutical Industries Ltd (TARO) has a year-to-date price change of 2.9%. Over the past six months, the figure is 1.51%. Looking at a longer horizon, the five-year price change stands at -43.62%.

help

Is Taro Pharmaceutical Industries Ltd (TARO) a profitable company?

Taro Pharmaceutical Industries Ltd (TARO) has a net income of $53.87M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 48.47% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 5.93% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $629.18M, with a revenue growth rate of 9.81%, providing insight into the company's sales performance and growth. The gross profit is $304.98M. Operating income is noted at $21.51M. Furthermore, the EBITDA is $74.41M.

help

What is the market capitalization of Taro Pharmaceutical Industries Ltd (TARO)?

Taro Pharmaceutical Industries Ltd (TARO) has a market capitalization of $1.62B. The average daily trading volume is 85.28K, indicating the stock's liquidity and investor engagement.